About fifteen people attended this webinar which provided the most recent updates of ongoing TB research within the IMI AMR Accelerator. The following speakers addressed the challenges of their respective TB projects:

• Michael Hoelscher (Medical University München) who gave an update and intro to UNITE4TB;
• Santiago Ferrer-Bazaga (Universidad Carlos III Madrid) who discussed some challenges from ERA4TB;
• Michel Pieren (BioVersys) who gave a clinical update from TRIC-TB.

These updated were followed by a panel discussion moderated by Frederik Deroose (Connecting Pharma), where some of these challenges were discussed in more detail, and some further opportunities for leveraging the TB focused initiatives have been discussed.